Earnings Call · Q4 FY2022·2023-03-28

Q4 22EPS +100.00%*·Rev n/aQ3 22EPS +26.52%·Rev n/aQ2 22EPS +56.38%·Rev n/aQ1 22EPS -38.57%·Rev n/a⚠ consensus missing

Arcturus Therapeutics Holdings Inc. ARCT

Neda Safarzadeh — Investor Relations or Communications

Joseph Payne — President and Chief Executive Officer

Andrew Sassine — Chief Financial Officer

+30.1%1d on move date+28.7% vs SPY3d+54.6%5d+74.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARCT calls or request research access.

More ARCT calls Browse calls Request research access